While preventative vaccines have significantly reduced the incidence of human papillomavirus (HPV), they offer no recourse for the millions of individuals already contending with active infections that can progress to cancer. Addressing this critical unmet need, researchers at Chiba University in
At the University of Southern California, a quiet revolution is underway, driven by visionary leadership and a historic philanthropic investment that is positioning the institution to fundamentally reshape how urologic cancers are diagnosed, treated, and potentially cured. Under the guidance of Dr.
In the world of oncology, the conventional wisdom has often been to hit cancer as hard as possible. But a groundbreaking study on immunotherapy for malignant melanoma is challenging that paradigm, suggesting that sometimes, less is more. We sit down with biopharma expert Ivan Kairatov to dissect
A groundbreaking pilot study from Bournemouth University suggests that the origins of endometriosis, a debilitating condition affecting one in ten women, may lie in a complex interaction between our ancient genetic heritage and the modern chemical environment. This new hypothesis proposes that
In the relentless fight against aggressive brain cancers, where progress is often measured in small, hard-won increments, a major clinical trial has delivered a monumental leap forward for a specific group of patients facing a daunting diagnosis. The recently concluded STELLAR Phase 3 clinical
Imagine a world where a single drug could shift the trajectory of blood cancer treatment, offering hope to thousands battling chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). At the recent American Society of Hematology (ASH) meeting in Orlando, Eli Lilly thrust its BTK
